Recorded Chinese product: 利福霉素钠氯化钠注射液利福霉素钠氯化钠注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

利福霉素钠是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:利福霉素钠Lifu Meisu Na。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:利福霉素钠-22a2c91b成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 利福霉素钠氯化钠注射液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 利福霉素钠Lifu Meisu Na.

Explore other medicines containing the same ingredient: 利福霉素钠 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 利福霉素钠氯化钠注射液Recorded Chinese product: 利福霉素钠氯化钠注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 250ml∶利福霉素钠0.5g(50万单位)(以利福霉素计)与2.25g氯化钠Recorded Chinese specification: 250ml∶利福霉素钠0.5g(50万单位)(以利福霉素计)与2.25g氯化钠

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 吉林万生药业有限责任公司Chinese legal name: 吉林万生药业有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20051804

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20051804

Manufacturer

Chinese legal name: 吉林万生药业有限责任公司

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20051804

生产企业

吉林万生药业有限责任公司

适应症

适用于结核杆菌感染,耐青霉素和耐新霉素的金黄色葡萄球菌(MRSA)及耐青霉素和耐新霉素凝固酶阴性的葡萄球菌(MRNCSA)等的联合治疗。

用法用量

静脉滴注。 1.成人:一般感染一次500mg,一日2次; 2.中重度感染:一次1000mg,一日2次,滴速不宜过快。 3.儿童:用量为一日10~30mg/kg体重,一日2次或遵医嘱。

不良反应

1.滴注过快时可出现暂时性巩膜或皮肤黄染。
2.少数病人可出现一过性肝脏损害、黄疸及肾损害。
3.其他不良反应有恶心、食欲不振及眩晕,偶见耳鸣及听力下降、过敏性皮炎等。

禁忌

肝病或肝损害者禁用。

注意事项

1.长期应用本品,偶见ALT轻度增高,停药后一般可自行恢复。
2.本品不宜与其他药物混合使用,以免药物析出。
3.用药后病人尿液呈红色,属于正常现象。
4.与异烟肼合用,对结核菌有协同抗菌作用,但对肝毒性亦增加。
5.用药期间应检查肝功能。

贮藏

密封,置阴凉处。

规格

250ml∶利福霉素钠0.5g(50万单位)(以利福霉素计)与2.25g氯化钠

证据Evidence

  • 批准文号: 国药准字H20051804
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.